Iovance Biotherapeutics, Inc. Share Price

NASDAQ: IOVA

Mid Cap

$2.27

-0.15

(-5.99%)

as on September 13, 2025 at 1:29 am IST

$₹

Iovance Biotherapeutics, Inc. Stock Performance

as on September 13, 2025 at 1:29 am IST

Day's High
$2.27
Day's Price Range
$2.42
$2.27
6.61%
Upside
52 Week's Low
52 Week's High
$1.64
52-Week Price Range
$12.51
$2.27
27.82%
Downside
450.88%
Upside

Iovance Biotherapeutics, Inc. share price movements today

Previous Close: $2.42
Open: $2.42
Volume: 8.7M
Day's Low - High: $2.27 - $2.42
52 Week Low - High: $1.64 - $12.51

Iovance Biotherapeutics, Inc. Historical Returns

1 Month Return: -1.22 %
3 Month Return: + 8.04 %
1 Year Return: -76.6 %
3 Year Return: -77.98 %
5 Year Return: -92.37 %

Iovance Biotherapeutics, Inc. Stock Fundamentals & Key Indicators

Check Iovance Biotherapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$875.7M

EPS (TTM)

-1.1046

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-376.3M

Revenue (TTM)

241.5M

Profit Margin

-161.44%

Return On Equity TTM

2255000.00%

Iovance Biotherapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Iovance Biotherapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Iovance Biotherapeutics, Inc.	BUY	$875.7M	-92.37%	NA	-161.44%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	280.5%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	54.04%	28.08	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	2.03%	14.11	31.37%

Stock Returns calculator for Iovance Biotherapeutics, Inc. Stock including INR - Dollar returns

The Iovance Biotherapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Iovance Biotherapeutics, Inc. investment value today

Current value as on today

₹27,093

Returns

₹72,907

(-72.91%)

Returns from Iovance Biotherapeutics, Inc. Stock

₹78,046 (-78.05%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Iovance Biotherapeutics, Inc. Stock

Based on 20 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 20 analysts, 90% of analysts recommend a 'BUY' rating for Iovance Biotherapeutics, Inc.. Average target price of $9.1

Iovance Biotherapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Iovance Biotherapeutics, Inc..

What analysts predicted

75.05%UPSIDE

Target Price

$9.1

Current Price

$2.27

Analyzed by

20 Analysts

Target

$9.10

Iovance Biotherapeutics, Inc. target price $9.1, a slight upside of 75.05% compared to current price of $2.27. According to 20 analysts rating.

Iovance Biotherapeutics, Inc. Stock's Interest Amongst Investors

Investment in Iovance Biotherapeutics, Inc. Shares on INDmoney has dropped by -62.12% over the past 30 days, indicating reduced transactional activity.

Time period: August 14, 2025 to September 13, 2025

Change:-62.12% versus previous 30 day period

Search interest for Iovance Biotherapeutics, Inc. Stock has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 14, 2025 to September 13, 2025

Change:-56% versus previous 30 day period

Iovance Biotherapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	0	0	0	0	31	58	73	49	59
Gross Profit	-5	-1	-3	-13	-6	0	18	28	0	3
Operating Income	-110	-110	-118	-121	-117	-101	-89	-86	-121	-113
EBITDA	-105	-102	-108	-111	-107	-91	-77	-74	-106	-101
Interest Expense	3	-	-	3	-	-	-	-	-	-
Depreciation	5	7	9	9	9	10	11	11	11	11
Income Before Tax	-107	-107	-115	-118	-114	-98	-85	-77	-118	-109
Income Tax Expense	-3	0	-1	-1	-1	-1	-1	1	-1	1
Net Income	-103	-106	-113	-116	-112	-97	-83	-78	-116	-111
Net Profit Margin	0.00%	-44759.66%	-24255.86%	-24145.02%	-15800.84%	-312.16%	-142.67%	-106.60%	-235.51%	-186.25%

Iovance Biotherapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-	0	1	164
Gross Profit	0	0	0	0	-8	-8	-13	-21	-9	40
Operating Income	-27	-53	-92	-128	-206	-261	-342	-398	-460	-395
EBITDA	-26	-52	-91	-127	-205	-250	-328	-377	-427	-351
Interest Expense	0	-	-	-	-	2	0	2	-	-
Depreciation	-	-	0	0	1	1	13	21	29	43
Income Before Tax	-27	-52	-92	-123	-197	-259	-342	-395	-447	-375
Income Tax Expense	0	0	0	4	-10	-2	-14	-5	-3	-2
Net Income	-27	-52	-92	-123	-187	-259	-327	-389	-444	-372
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-163833.19%	-37345.42%	-226.84%

Iovance Biotherapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-106	-113	-116	-112	-97	-83	-78	-116	-111
Operating Cash Flow	-93	-84	-83	-122	-98	-58	-73	-103	-67
Investing Cash Flow	-156	-79	-72	-111	40	-48	23	15	13
Financing Cash Flow	1	202	0	193	152	41	2	143	13
Change in Cash	-253	37	-152	-40	94	-64	-48	55	-39

Iovance Biotherapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-52	-92	-123	-197	-259	-342	-395	-444	-372
Operating Cash Flow	-32	-78	-101	-158	-205	-227	-292	-361	-352
Investing Cash Flow	8	58	-386	90	-317	0	256	-155	-96
Financing Cash Flow	96	58	424	6	576	239	190	462	390
Change in Cash	73	38	-63	-62	53	11	153	-56	-59

Global Institutional Holdings in Iovance Biotherapeutics, Inc.

Funds	Holdings
Vanguard Group Inc	8.12%
Mhr Fund Management Llc	7.14%
BlackRock Inc	7.11%
Perceptive Advisors LLC	3.72%
State Street Corp	3.23%

See all

Insights on Iovance Biotherapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 153.7%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 125.6% return, outperforming this stock by 204.9%
NEGATIVE IMPACT
Price Dip
In the last 7 days, IOVA stock has moved down by -8.8%

About Iovance Biotherapeutics, Inc.

iovance biotherapeutics is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes (til). this approach, also known as adoptive t-cell therapy, was initially developed by dr. steven a. rosenberg at the national cancer institute (nci). in phase 2 clinical trials conducted at the nci, 56% and 24% of patients treated with this technology were reported by nci to have achieved objective and complete response criteria, respectively. our lead product candidate is an autologous, ready-to-infuse cell therapy, that has demonstrated distinctive efficacy in the treatment of metastatic melanoma. in addition to metastatic melanoma, carcinoma of the head and neck and cervical cancer our til therapy technology is potentially applicable to many other tumor types, including ovarian, breast, bladder, colorectal and other cancers. as we continue advancing our current clinical programs through the introduction of manufacturing and logistical

Organisation	Iovance Biotherapeutics, Inc.
Headquarters	825 Industrial Road, San Carlos, CA, United States, 94070
Industry	Health Technology
CEO	Dr. Frederick G. Vogt Esq., J.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Iovance Biotherapeutics, Inc.

Name	Title
Dr. Friedrich Graf Finckenstein M.D.	Chief Medical Officer
Dr. Raj K. Puri M.D., Ph.D.	Chief Regulatory Officer
Ms. Corleen M. Roche	Chief Financial Officer
Mr. Matthew W. Rosinack	Principal Accounting Officer
Ms. Sara Pellegrino	Senior Vice President of Investor Relations & Corporate Communications
Mr. Howard B. Johnson M.B.A.	Chief Business Officer
Mr. Brian Shew M.B.A.	Senior VP & Head of Digital and Information Technology
Dr. Frederick G. Vogt Esq., J.D., Ph.D.	Interim CEO, President, General Counsel, Corporate Secretary & Director
Dr. Igor P. Bilinsky Ph.D.	Chief Operating Officer
Ms. Tracy Winton	Executive Vice President of Human Resources

FAQs

What is Iovance Biotherapeutics, Inc. share price today?

Iovance Biotherapeutics, Inc. share price today is $2.27 as on September 13, 2025 at 1:29 am IST at the close of the market. Iovance Biotherapeutics, Inc. share today touched a day high of $2.42 and a low of $2.27.

What is the 52 week high and 52 week low for Iovance Biotherapeutics, Inc. share?

Iovance Biotherapeutics, Inc. share touched a 52 week high of $12.51 on November 7, 2024 and a 52 week low of $1.64 on May 19, 2025. Iovance Biotherapeutics, Inc. stock price today i.e. September 13, 2025 at 1:29 am IST is closed at $2.27,which is 81.85% down from its 52 week high and 38.54% up from its 52 week low.

What is Iovance Biotherapeutics, Inc.'s market capitalisation today?

Iovance Biotherapeutics, Inc. market capitalisation is $0.00T as on September 13, 2025 at 1:29 am IST.

How to invest in Iovance Biotherapeutics, Inc. Stock (IOVA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Iovance Biotherapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Iovance Biotherapeutics, Inc. Shares that will get you 0.6608 shares as per Iovance Biotherapeutics, Inc. share price of $2.27 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Iovance Biotherapeutics, Inc. Stock (IOVA) from India?

Indian investors can start investing in Iovance Biotherapeutics, Inc. (IOVA) shares with as little as ₹88.27 or $1 (as of September 13, 2025 at 10:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Iovance Biotherapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on September 13, 2025 at 10:40 pm IST). Based on Iovance Biotherapeutics, Inc. share’s latest price of $2.27 as on September 13, 2025 at 1:29 am IST, you will get 4.4053 shares of Iovance Biotherapeutics, Inc.. Learn more about fractional shares .

What are the returns that Iovance Biotherapeutics, Inc. has given to Indian investors in the last 5 years?

Iovance Biotherapeutics, Inc. stock has given -92.37% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?